Specificity of resting-state heart rate variability in psychosis: A comparison with clinical high risk, anxiety, and healthy controls.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
04 2019
Historique:
received: 14 08 2018
revised: 06 12 2018
accepted: 07 12 2018
pubmed: 24 12 2018
medline: 14 5 2020
entrez: 22 12 2018
Statut: ppublish

Résumé

Maladaptability, particularly of autonomic activity, is described as a central component of vulnerability-stress-models for the pathogenesis of psychotic symptoms. Investigating heart rate variability (HRV) as an index of autonomic adaptability is thus likely to improve our understanding of psychosis. In clinically vulnerable groups for psychosis, it is unclear whether maladaptability is already evident. Moreover, to investigate specificity, direct comparisons to other mental disorders are required. In the present study, we analyzed 3 min of resting-state heart rate, HRV, and negative affect in 130 participants; consisting of participants with psychotic disorders (PSY; n = 44), clinical high-risk for psychosis (CHR; n = 22), anxiety disorders (anxiety controls, AC; n = 29) and healthy controls (HC; n = 35). ANCOVAs controlling for age revealed significant group differences for both investigated vagal HRV parameters, which were reduced in PSY compared to HC. The high-frequency domain HRV in PSY was also lower than in CHR and - in a non-significant trend - than in AC. Also, ANOVAs for heart rate and negative affect revealed significant increases in PSY compared to HC. Exploratory analyses of medication effects showed moderate dosage associations with heart rate and high-frequency HRV. Thus, in the present study, the activity of the autonomic nervous system was altered in psychosis but not in an at-risk group. A potential specificity of the effect can be speculated in contrast to anxiety disorders. Future studies should investigate the predictive value of HRV for increased stress-sensitivity or transition to clinical symptoms as well as the implications for daily threat perception and symptom maintenance.

Identifiants

pubmed: 30573408
pii: S0920-9964(18)30697-2
doi: 10.1016/j.schres.2018.12.009
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-95

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Annika Clamor (A)

Clinical Psychology and Psychotherapy, Institute of Psychology, Faculty of Psychology and Human Movement Sciences, Universität Hamburg, Germany. Electronic address: annika.clamor@uni-hamburg.de.

Johanna Sundag (J)

Clinical Psychology and Psychotherapy, Institute of Psychology, Faculty of Psychology and Human Movement Sciences, Universität Hamburg, Germany.

Tania M Lincoln (TM)

Clinical Psychology and Psychotherapy, Institute of Psychology, Faculty of Psychology and Human Movement Sciences, Universität Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH